Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Big data opens a window onto wellness

Nature Biotechnology volume 35, pages 720–721 (2017)Cite this article

Subjects

Longitudinal multi-omics data, clinical tests and biomarker analyses across a large cohort lay the groundwork for understanding the transition from wellness to disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: An individual undergoes multi-modality molecular testing.

References

  1. Wilson, P.W. et al. Circulation 97, 1837–1847 (1998).

    Article  CAS  Google Scholar 

  2. Price, N.D. et al. Nat. Biotechnol. 35, 747–756 (2017).

    Article  CAS  Google Scholar 

  3. Sheridan, C. Nat. Biotechnol. 33, 887–889 (2015).

    Article  CAS  Google Scholar 

  4. Li, X. et al. PLoS Biol. 15, e2001402 (2017).

    Article  Google Scholar 

  5. Telenti, A. et al. Proc. Natl. Acad. Sci. USA 113, 11901–11906 (2016).

    Article  CAS  Google Scholar 

  6. Dewey, F.E. et al. Science 354, aaf6814 (2016).

    Article  Google Scholar 

  7. Sudlow, C. et al. PLoS Med. 12, e1001779 (2015).

    Article  Google Scholar 

  8. Morgan, A.A., Chen, R. & Butte, A.J. Genome Med. 2, 30 (2010).

    Article  Google Scholar 

  9. Butte, A.J. Proc. Natl. Acad. Sci. USA 113, 12344–12346 (2016).

    Article  CAS  Google Scholar 

  10. Kasahara, A.K., Singh, R.J. & Noymer, A. PLoS One 8, e65785 (2013).

    Article  CAS  Google Scholar 

  11. Taylor, N.P. Fierce Biotech http://www.fiercebiotech.com/genomics/venter-s-human-longevity-starts-50-000-health-testing-service (2015).

Download references

Acknowledgements

A.J.B. is supported by the National Institutes of Health under award number 1OT2OD024611. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

  1. Atul J. Butte is at the Institute for Computational Health Sciences, University of California, San Francisco, USA.,

    Atul J Butte

Authors
  1. Atul J Butte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atul J Butte.

Ethics declarations

Competing interests

A.J.B. has a minor investment in Illumina and other biotech companies. He is a cofounder and consultant to Personalis, a company offering services in medical genome sequencing. A.J.B. is a scientific advisor to Geisinger Health System, Helix, and uBiome. In the recent past, he has been a consultant to Regeneron, 10x Genomes, Verinata and Pathway Genomics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Butte, A. Big data opens a window onto wellness. Nat Biotechnol 35, 720–721 (2017). https://doi.org/10.1038/nbt.3934

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3934

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research